Stratos Wealth Partners’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-3,607
Closed -$256K 2963
2018
Q2
$256K Hold
3,607
0.01% 810
2018
Q1
$375K Hold
3,607
0.02% 647
2017
Q4
$363K Buy
+3,607
New +$266K 0.02% 639

Other funds holding ANAB

Stratos Wealth Partners's ANAB Position: Q3 2018 in Review

Stratos Wealth Partners sold out of AnaptysBio (ANAB) in Q3 2018, closing a stake of 3,607 shares — an estimated $256K sold.

Stratos Wealth Partners first reported a position in ANAB in Q4 2017 and held it in 3 quarters. The position peaked at $375K in Q1 2018. 129 funds tracked by Wall St. Rank hold ANAB as of Q3 2018.

  • Stratos Wealth Partners reported no remaining AnaptysBio position as of Q3 2018 after selling out during the quarter.
  • Stratos Wealth Partners sold 3,607 AnaptysBio shares in Q3 2018, an estimated $256K.
  • Stratos Wealth Partners first reported a position in AnaptysBio in Q4 2017 and held it in 3 quarters.
  • Stratos Wealth Partners's AnaptysBio position peaked at $375K in Q1 2018.
  • 129 funds tracked by Wall St. Rank held AnaptysBio as of Q3 2018.

Based on Stratos Wealth Partners's 13F filing for Q3 2018, filed 2 Nov 2018.